AngioDynamics (ANGO)
(Real Time Quote from BATS)
$7.38 USD
-0.10 (-1.34%)
Updated Jul 24, 2024 11:22 AM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/2/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 70.00% |
ABR | 1.00 |
Earnings ESP
|
13.00% |
---|---|
Current Year | -0.47 |
Next Year | -0.26 |
EPS (TTM) | -0.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (5/2025) |
Next Year (5/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 68.50M | 71.24M | 285.28M | 312.08M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 69.00M | 71.50M | 286.13M | 318.16M |
Low Estimate | 68.10M | 71.00M | 284.70M | 306.00M |
Year ago Sales | 78.68M | 79.07M | 303.91M | 285.28M |
Year over Year Growth Est. | -12.93% | -9.90% | -6.13% | 9.40% |
Earnings Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (5/2025) |
Next Year (5/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.11 | -0.47 | -0.26 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -0.13 | -0.10 | -0.40 | NA |
High Estimate | -0.13 | -0.09 | -0.40 | -0.23 |
Low Estimate | -0.21 | -0.15 | -0.61 | -0.29 |
Year ago EPS | -0.12 | -0.05 | -0.38 | -0.47 |
Year over Year Growth Est. | -41.67% | -120.00% | -23.68% | 45.39% |
Agreement - Estimate Revisions
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (5/2025) |
Next Year (5/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (5/2025) |
Next Year (5/2026) |
|
---|---|---|---|---|
Current | -0.17 | -0.11 | -0.47 | -0.26 |
7 Days Ago | -0.19 | -0.14 | -0.57 | -0.26 |
30 Days Ago | -0.20 | -0.14 | -0.58 | -0.29 |
60 Days Ago | -0.20 | -0.14 | -0.57 | -0.28 |
90 Days Ago | -0.20 | -0.13 | -0.53 | -0.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (5/2025) |
Next Year (5/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.10 | -0.41 | -0.23 |
Zacks Consensus Estimate | -0.17 | -0.11 | -0.47 | -0.26 |
Earnings ESP | 13.00% | 16.17% | 14.44% | 11.54% |
Surprise - Reported Earnings History
Quarter Ending (5/2024) |
Quarter Ending (2/2024) |
Quarter Ending (11/2023) |
Quarter Ending (8/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.16 | -0.05 | -0.12 | NA |
Estimate | -0.20 | -0.14 | -0.09 | -0.14 | NA |
Difference | 0.14 | -0.02 | 0.04 | 0.02 | 0.05 |
Surprise | 70.00% | -14.29% | 44.44% | 14.29% | 28.61% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more